TickerFactsScreenerDevelopers

BioRestorative Therapies, Inc. (BRTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$2.07M2011: -$3.55M2012: -$5.57M2013: -$4.75M2014: -$4.92M2015: -$7.17M2016: -$7.79M2017: -$8.37M2018: -$7.65M2019: -$8.43M2020: -$2.75M2021: -$26.31M2022: -$18.97M2023: -$15.22M2024: -$11.56M2025: -$15.65M-$15.65M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$15.65M-35.4%
2024-$11.56M+24.1%
2023-$15.22M+19.8%
2022-$18.97M+27.9%
2021-$26.31M-855.9%
2020-$2.75M+67.4%
2019-$8.43M-10.3%
2018-$7.65M+8.7%
2017-$8.37M-7.6%
2016-$7.79M-8.6%
2015-$7.17M-45.7%
2014-$4.92M-3.6%
2013-$4.75M+14.7%
2012-$5.57M-56.9%
2011-$3.55M-71.6%
2010-$2.07M—